The Role of Carotid Flow Time-Based Fluid Administration in Caesarean Section

Sponsor
Cukurova University (Other)
Overall Status
Completed
CT.gov ID
NCT06048497
Collaborator
(none)
72
2
7.6
36
4.7

Study Details

Study Description

Brief Summary

It has been reported that corrected carotid flow time (FTc) may indicate the responsiveness of spontaneously breathing patients to fluid therapy. The primary objective of the study is to determine the effect of fluid preload applied to patients with preanesthetic FTc values below the cut-off value on the incidence of hypotension in cesarean section (C/S) surgery. Pregnant women who underwent cesarean section under spinal anesthesia were included in this prospective study. In the preoperative care unit, patients were assigned to two groups according to their baseline FTc values. Patients with baseline FTc < 327 ms were assigned to the first group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc > 327 ms. On the other hand, patients with baseline FTc > 327 ms were assigned to the second group, and preload fluid was not administered to these patients. Intraoperative hemodynamic data were recorded for each patient.

Condition or Disease Intervention/Treatment Phase
  • Device: Corrected carotid flow time measurement guided fluid preload

Study Design

Study Type:
Observational
Actual Enrollment :
72 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Role of Carotid Flow Time-Based Fluid Administration in the Incidence of Hypotension After Spinal Anesthesia in Patients Undergoing Caesarean Section
Actual Study Start Date :
Nov 15, 2022
Actual Primary Completion Date :
May 20, 2023
Actual Study Completion Date :
Jul 5, 2023

Arms and Interventions

Arm Intervention/Treatment
Preload

Patients with baseline FTc < 327 ms were assigned to the preload group, and Ringer Lactate (RL) preload fluid administration to these patients was continued until FTc > 327 ms.

Device: Corrected carotid flow time measurement guided fluid preload
Preoperative FTcs of pregnant women who underwent C/S operation were measured, and those below the cut-off value (327 ms) determined in previous studies were preloaded with Ringer Lactate until FTc was > 327 ms.

Non-preload

Patients with baseline FTc > 327 ms were assigned to the non-preload group, and preload fluid was not administered to these patients

Outcome Measures

Primary Outcome Measures

  1. The incidence of intra-operative hypotension [During surgery]

    Hypotension definitions included systolic arterial pressure (SAP) below 80 mmHg, or mean arterial pressure (MAP) below 65 mmHg, or a decrease in SAP of more than 30% below baseline, or a decrease in MAP of more than 20% below baseline, or any combination of all these definitions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 20-40 years of age pregnant women

  • American Society of Anesthesiologists (ASA) physical status-II patients

  • Uncomplicated, singleton, term pregnancy

  • Elective C/S surgery

Exclusion Criteria:
  • Placental disorders

  • Gestational hypertensive disorders

  • Morbid obesity (BMI>39 kg/m2)

  • Carotid stenosis more than 50%

  • Baseline SAP more than 160 mmHg

  • Arrhythmia

  • History of cardiovascular or cerebrovascular disease, and chronic kidney disease (estimated glomerular filtration rate <60 mL/min/1.73 m2)

  • Emergency surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cukurova University Adana Saricam Turkey 01330
2 Çukurova University; Faculty of Medicine Adana Sarıçam Turkey 01330

Sponsors and Collaborators

  • Cukurova University

Investigators

  • Principal Investigator: Demet Laflı Tunay, Dr., Çukurova University, Balcalı Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Demet Laflı Tunay, Dr., Cukurova University
ClinicalTrials.gov Identifier:
NCT06048497
Other Study ID Numbers:
  • FTCCS
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 21, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Demet Laflı Tunay, Dr., Cukurova University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2023